Chemical Confirmation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Chemical Confirmation
Analytical detection techniques help combat counterfeit drugs.


Pharmaceutical Technology
Volume 35, Issue 8, pp. 48-50


PHOTO COURTESY OF TRUTAG TECHNOLOGIES
Pharmaceutical manufacturers can choose from a variety of anticounterfeiting technologies to deal with the ever-growing problem of counterfeit drugs in the supply chain. FDA and industry experts recommend a layered approach to protecting the integrity of the supply chain, which combines technologies for antitampering, serialization, and authentication (in the form of overt, covert, or forensic features) applied to the packaging or dosage form. Analytical detection methods can confirm the authenticity of a drug product by using technologies such as portable spectrometer-based readers that authenticate in the field, thin-layer chromatography kits that quickly verify the presence and amount of active pharmaceutical ingredient (API), or analytical laboratory screening services that offer extensive testing of packaging and finished dosage forms for counterfeits.

On-dose protection

TruTag Technologies in Honolulu developed an anticounterfeiting solution in the form of a covert silica microtag that is edible, economical, heat resistant, and can be mixed into a coating, dye, or ink. The microtag is encoded with a spectral pattern chosen from a library of up to a trillion unique patterns, Peter Wong, chief operating officer of TruTag Technologies, explains. "Therefore, our microtag is like a covert, 'edible barcode' and is as flexible a business tool as a traditional printed barcode," he says. The company's product was recently recognized as a promising new technology for anticounterfeiting by winning "Most Likely to Succeed" in the life sciences category at the Launch: Silicon Valley 2011 competition, an event focused on identifying emerging technology startups.

The microtags, which can be applied to a solid dosage form or to packaging components, are authenticated using a portable spectrometer-based optical reader. Wong says the company has received "quite a bit of interest" in applying the microtags to bulk API and are open to testing with an interested partner. TruTag's portable readers can confirm the authenticity of the product through a clear blister pack, so the product does not have to be destroyed. The microtags can also link to additional information stored in a manufacturer's database, such as e-Pedigree and track-and-trace systems.

Wong says that in the company's development work, the application of the microtags has been relatively straightforward. TruTag was able to combine small quantities of microtags with a tablet-coating mix, which was then sprayed onto solid oral dosage forms using standard industry pan coaters. Because silica (silicon dioxide) is a generally-recognized-as-safe (GRAS) material, says Wong, under the framework of FDA's draft guidance, Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting (1), the agency's filing process may be as simple as including the addition of TruTag microtags as an annual reportable change if the product already had silica as an ingredient, or require a CBE-30 supplement if silica is a new ingredient to the product.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here